Evidence map›Paper›PMID 37515131›Full record

ArticleViruses2023

SARS-CoV-2 Inactivation in Aerosol by Means of Radiated Microwaves.

Antonio Manna, Davide De Forni, Marco Bartocci, Nicola Pasculli, Barbara Poddesu, Florigio Lista, Riccardo De Santis, Donatella Amatore, Giorgia Grilli, Filippo Molinari and 2 more

Abstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Antonio MannaElettronica S.p.A., Via Tiburtina Valeria, Km 13.700, 00131 Rome, Italy.ORCID 0000-0001-9776-3300
Davide De ForniViroStatics s.r.l., Viale Umberto I, 46, 07100 Sassari, Italy.ORCID 0009-0002-2555-1397
Marco BartocciElettronica S.p.A., Via Tiburtina Valeria, Km 13.700, 00131 Rome, Italy.
Nicola PasculliElettronica S.p.A., Via Tiburtina Valeria, Km 13.700, 00131 Rome, Italy.
Barbara PoddesuViroStatics s.r.l., Viale Umberto I, 46, 07100 Sassari, Italy.
Florigio ListaDefense Institute for Biomedical Sciences, 00184 Rome, Italy.
Riccardo De SantisDefense Institute for Biomedical Sciences, 00184 Rome, Italy.ORCID 0000-0002-2097-6663
Donatella AmatoreDefense Institute for Biomedical Sciences, 00184 Rome, Italy.
Giorgia GrilliDefense Institute for Biomedical Sciences, 00184 Rome, Italy.
Filippo MolinariDefense Institute for Biomedical Sciences, 00184 Rome, Italy.
Alberto Sangiovanni VincentelliElettronica S.p.A., Via Tiburtina Valeria, Km 13.700, 00131 Rome, Italy.ORCID 0000-0003-1298-8389
Franco LoriViroStatics s.r.l., Viale Umberto I, 46, 07100 Sassari, Italy.ORCID 0000-0002-5928-172X

Funding

CSRD VA 1
6 · The paper itself

Abstract

Coronaviruses are a family of viruses that cause disease in mammals and birds. In humans, coronaviruses cause infections on the respiratory tract that can be fatal. These viruses can cause both mild illnesses such as the common cold and lethal illnesses such as SARS, MERS, and COVID-19. Air transmission represents the principal mode by which people become infected by SARS-CoV-2. To reduce the risks of air transmission of this powerful pathogen, we devised a method of inactivation based on the propagation of electromagnetic waves in the area to be sanitized. We optimized the conditions in a controlled laboratory environment mimicking a natural airborne virus transmission and consistently achieved a 90% (tenfold) reduction of infectivity after a short treatment using a Radio Frequency (RF) wave emission with a power level that is safe for people according to most regulatory agencies, including those in Europe, USA, and Japan. To the best of our knowledge, this is the first time that SARS-CoV-2 has been shown to be inactivated through RF wave emission under conditions compatible with the presence of human beings and animals. Additional in-depth studies are warranted to extend the results to other viruses and to explore the potential implementation of this technology in different environmental conditions.

Indexed as

COVID-19SARS-CoV-2AnimalsEuropeHumansMammalsMicrowavesRespiratory Aerosols and Dropletsairborne pathogensair transmissionCOVID-19microwave inactivationSARS-CoV-2SRET

Identifiers

PMID37515131
PMCPMC10386662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.